stockrowHarmony Biosciences Holdings, Inc. (HRMY) vs Maravai LifeSciences Holdings, Inc. (MRVI)
- Harmony Biosciences Holdings, Inc. HRMY 33.04 +1.76%
- Maravai LifeSciences Holdings, Inc. MRVI 7.52 +7.74%
Harmony Biosciences Holdings, Inc. and Maravai LifeSciences Holdings, Inc. are both Biotechnology companies. Harmony Biosciences Holdings, Inc. and Maravai LifeSciences Holdings, Inc. are of similar size ($1.9B and $1.8B). Maravai LifeSciences Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Harmony Biosciences Holdings, Inc. trades at 10.7×. Harmony Biosciences Holdings, Inc. grew revenue faster over the last twelve months: 19.8% against 10.7%. Harmony Biosciences Holdings, Inc. has the higher net margin (18.1% vs −30.8%) and the higher return on invested capital (30.5% vs −13.6%). Across the 18 metrics below, Harmony Biosciences Holdings, Inc. leads on 16 and Maravai LifeSciences Holdings, Inc. on 2.
Valuation
Profitability
| Metric | HRMY | MRVI | Biotechnology median |
|---|---|---|---|
| Gross margin | 74.03% | 39.15% | 68.51% |
| Operating margin | 22.17% | (45.38%) | 0.00% |
| Net margin | 18.05% | (30.83%) | 0.00% |
| Free cash flow margin | 32.65% | (5.89%) | 0.00% |
| Return on equity | 18.73% | (17.01%) | (51.96%) |
| Return on assets | 13.30% | (9.06%) | (46.06%) |
| Return on invested capital | 30.45% | (13.62%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack